The Clinicopathologic Characteristics of Patients with Gastric Carcinoid Tumor.
10.5230/jkgca.2009.9.4.262
- Author:
Jeong Moon JANG
1
;
Seong Ho KONG
;
Hong Man YOON
;
Hye Seong AHN
;
Hyuk Joon LEE
;
Won Jae YOON
;
Sang Kyoon KIM
;
Han Kwang YANG
;
Kuhn Uk LEE
Author Information
1. Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. hkyang@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Gastric carcinoid;
Clinicopathologic characteristics;
Treatment;
Survival rate
- MeSH:
Age of Onset;
Carcinoid Tumor;
Female;
Humans;
Incidence;
Lymph Nodes;
Neoplasm Metastasis;
Palliative Care;
Retrospective Studies;
Survival Rate
- From:Journal of the Korean Gastric Cancer Association
2009;9(4):262-268
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We wanted to analyze the clinicopathologic characteristics of patients with gastric carcinoid tumor, which is a rare gastric tumor (less than 2% of all gastric tumors). MATERIALS AND METHODS: We reviewed all the carcinoid patients who were treated from 1996 to 2006. The clinicopathologic characteristics, the treatment modalities and the survival rates were retrospectively analysed. RESULTS: There were 8 type I patients and 10 type III patients, but there were no type II patients. The mean age of onset for type I was 47.75 years and that for type III was 57.90 years. More type III patients were female, but the gender ratio of type I patients was equal at a ratio of 1:1. There were 4 cases of solitary tumor, which were all T1 except for one case, and there was neither distant metastasis nor lymph node involvement for the type T1 cases. In the 13 patients who had no metastasis, 5 underwent endoscopic mucosal resection and 8 underwent surgery, and their combined 5 year survival rate was 92.3%. For the 5 cases who had metastastses, their mean survival was 22 months and especially, 3 of them underwent palliative surgery and their median survival were 24 months (95%, +/-6.52). CONCLUSION: Higher incidence of type III gastric carcinoid tumor and less multiplicity in type I gastric tumor were identified in our study compared with previous reports. For the type III cases, there were some noteable differences compared with the Western country's survival rate for the patients who underwent palliative surgery, so physicians must pay close attention to the definite clinicopathologic characteristics of gastric carcinoid patients.
